Skip to content

News

Category: News

Peace of Mind after Developing a Pancreatic Cyst: Hertford Mother Participates in Cellvizio Study

Linda was diagnosed with a pancreatic cyst. Her consultant gastroenterologist, Dr. Stephen Pereira, performed a Cellvizio procedure and was able to rule out cancer immediately afterwards.

“It felt like my life was on hold,” says Linda Bartlett, a 41-year-old mother of two who found out she had a cyst on her pancreas in March 2014.
Linda lives in a town called Hertford in southern England where she cares for the elderly and spends her free time gardening and cross stitching. When she began to experience abdominal discomfort that led to trouble eating and weight loss, Linda went to her doctor.
At first she thought she might be dealing with inflammatory bowel disease, but a CT scan revealed a mass on her pancreas. A subsequent MRI confirmed it was a cyst. The next step would be to determine whether it was cancerous.
“I was shocked because I thought it was cancer,” recalls Linda. “My family has a history with cancer issues. My mother is prone to cysts and my husband has had cancer. It was a stressful time.”
Linda was referred to Dr. Stephen Pereira, a consultant gastroenterologist and hepatologist at University College London. Dr. Pereira is one of the first in the UK to use endomicroscopy with Cellvizio to examine pancreatic cysts and offered Linda an opportunity to participate in a clinical study.

Find out what you need to know about pancreatic cysts

“The ability to rapidly and accurately diagnose pancreatic cysts is important because it reduces wait time for the patient and allows doctors to make diagnoses with more confidence,” says Dr. Pereira. “Microscopic imaging with Cellvizio during standard endoscopies allows us to see and assess individual cells in real-time.”
Linda had no prior experience with endoscopies but was willing to participate in the study.
A benign pancreatic cyst can be distinguished from a potentially malignant one by the appearance of the cyst wall. After using Cellvizio to view Linda’s cyst wall for the first time, Dr. Pereira explained that it had a supervascular network of tiny vessels which is typical of a benign cyst. The procedure took less than 30 minutes and results were instantaneous.
“Another key advantage of this technology is that patients like Linda can avoid undergoing major preventative pancreatic surgery,” adds Dr. Pereira. “In this case we were able to rule out cancer and sent Linda home. Since this is a relatively new procedure, we do follow-up with patients in a standard way while we gain more experience with Cellvizio.”
“It gave me peace of mind,” says Linda. “There may be others who are not aware of the options available when diagnosed with a pancreatic cyst. Cellvizio Targeted Biopsy helped me return to my life and continue doing the things I love doing.”
Several published clinical trials show that endomicroscopy with Cellvizio provides an accurate description of a pancreatic cyst in about eight out of ten patients. In cases where the image is not conclusive, a traditional aspiration of fluid can still be taken. A clinical study is ongoing and is currently recruiting patients from the Royal Free Hospital and University College Hospital in London as well as Addenbrooke’s Hospital in Cambridge. Soon patients will also be able to join the study at Newcastle’s Freeman Hospital and Nottingham’s Queen’s Medical Centre.

Find a physician offering Cellvizio targeted Biopsy near you 

New Research at Mayo Clinic Describes Molecular Steps Leading to Pancreatic Cancer

We know that pancreatic cancer is so dangerous because symptoms do not usually occur until advanced stages. But what if we knew the steps that lead to the formation of precancerous lesions at the molecular level? Maybe cancer could be identified earlier. Better yet, maybe the development of the lesions could be stopped.
Continue reading “New Research at Mayo Clinic Describes Molecular Steps Leading to Pancreatic Cancer”

Pancreatic Cancer Awareness Month: Let’s Work Together to Diagnose Cancer Faster

purple-cellvizio-pancreatic-cancer-awareness-nov2014
Photo Credit: @ElementalHCare

Pancreatic cancer is often found late and spreads quickly. This makes it difficult to treat – it’s predicted to become the second leading cause of cancer-related death in the United States by 2030.i  The American Cancer Society estimates about 46,000 people will be diagnosed with pancreatic cancer in the US in 2014.ii

Cancerous pancreatic cysts are hard to catch because they often don’t cause any early symptoms, but improvements in imaging technology are helping physicians find these cysts more frequently. We believe not knowing the nature of a pancreatic cyst may soon become a thing of the past. And improved awareness and better funding will only help physicians diagnose cancer faster.

This November, Mauna Kea Technologies is joining tens of thousands of people around the world in recognizing Pancreatic Cancer Awareness Month and the first ever World Pancreatic Cancer Day on November 13th.

International non-profit organizations including the Pancreatic Cancer Action Network in the US and Pancreatic Cancer Action in the UK are coming together to raise awareness, improve research funding, and provide support for individuals and families living with the disease.

Purple Selfie Image
Photo Credit: @ElementalHCare

Here are a few ways you can get involved and show your support this month:

  • Wear purple!

Pancreatic Cancer Action Network has organized “Purple for a Purpose” for World Pancreatic Cancer Day. Celebrities, media influencers, on-air talent and other supporters will wear purple to raise awareness.

  • Use social media!

Pancreatic Cancer Action is asking individuals to take and share a #purplepselfie on social media.

Pancreatic Cancer Action Network invites you to join the “Wage Hope” campaign this month by visiting www.facebook.com/jointhefight and following @PanCAN on Twitter. Actions include changing Facebook profiles and cover photos and sharing and retweeting content.

i Rahib, Lola. “Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States.” Cancer Research. Published online May 19, 2014. http://cancerres.aacrjournals.org/content/early/2014/03/25/0008-5472.CAN-14-0155.full.pdf+html.

ii American Cancer Society. “What are the key statistics about pancreatic cancer?” June 11, 2014. http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics.

Cellvizio Targeted Biopsy helped Niloofar Shamloo to go back to her painting with peace of mind

Niloofar Shamloo is a painter who suddenly fell ill. She was diagnosed with inflammatory bowel disease ulcerative colitis. But doctors feared it could be the sign of something even worse, like pancreatic cancer. Using a confocal endomicroscope, doctors were able to give her a clean bill of health without having to resort to an laboratory invasive biopsy. With Cellvizio Targeted Biopsy, Niloofar Shamloo was able to go back to her painting with peace of mind.
Read more about her experience and watch a video of her story.